Andere talen Quest PharmaTech Inc.

Aandelen

QPT

CA74836M1068

Vertraagde tijd Toronto S.E. Andere beurzen 21:27:30 18-06-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
0,025 ^CAD	-.--%		-.--%	-54,55%

28/06	Quest PharmaTech Inc. rapporteert resultaten voor het eerste kwartaal dat eindigde op 30 april 2024	CI
30/05	Quest Pharmatech Inc. kondigt de benoeming aan van Bradley J. Glass in de Raad van Bestuur	CI

Andere talen

Krijg toegang tot al het nieuws: wees als eerste op de hoogte en reageer voordat de beurs dat doet!

Gratis inschrijven

Quest PharmaTech Inc. Reports Earnings Results for the First Quarter Ended April 30, 2024	28/06
Quest PharmaTech Announces Filing of 2024 Year End Financial Statements and Restated Fiscal 2023 Financial Statements, and Appointment of New Director	30/05
Quest Pharmatech Inc. Announces the Appointment of Bradley J. Glass to the Board of Directors	30/05
Quest PharmaTech Inc. Reports Earnings Results for the Full Year Ended January 31, 2024	29/05
Quest PharmaTech Brief: Says Quest has a 42.5% ownership interest in OncoQuest; Adds dividend income will be used by Quest for general corporate purposes	30/01
Quest PharmaTech Brief: Received a cash dividend payment from OncoQuest Inc. of approximately C$685,000	30/01
Quest Receives Cash Dividend Payment from OncoQuest	30/01
Quest PharmaTech Inc. Says Oregovomab Phase III Clinical Study Fails Futility Analysis	24/01
Quest PharmaTech Inc. - Oregovomab Phase III Clinical Study fails futility analysis, Data Safety Monitoring Board Recommends Overall Survival Follow Up for Potential Late Immune Effects and Clinical Benefits	24/01
Oregovomab Phase III Clinical Study fails futility analysis; Data Safety Monitoring Board Recommends Overall Survival Follow Up for Potential Late Immune Effects and Clinical Benefits	23/01
Quest PharmaTech Inc. Receives Recommendations from the Data Safety Monitoring Board to Discontinue Oregovomab Phase III Clinical Study	23/01
Quest PharmaTech Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended October 31, 2023	13/12
Quest PharmaTech Inc. Reports Earnings Results for the Second Quarter and Six Months Ended July 31, 2023	21-09-23
Quest PharmaTech Provides Corporate Update	13-09-23
Quest PharmaTech Announces Results from AGM	14-07-23
Quest PharmaTech Provided Product Development Update	10-07-23
Quest PharmaTech Provides Product Development Update	10-07-23
Quest PharmaTech Inc. Provides Product Development Update	10-07-23
Quest PharmaTech Inc. Reports Earnings Results for the First Quarter Ended April 30, 2023	29-06-23
Quest PharmaTech Provides Corporate Update	09-06-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Quest PharmaTech Inc.

Aandelen

QPT

CA74836M1068

Andere talen

Filters